DS68702229 (compound 44) was identified as a potent NAMPT activator (EC50 = 0.046 μM) that increases cellular NAD+ levels and is a promising anti-obesity drug candidate (Akiu et al., 2021a). Here, NAMPT is linked to obesity due to melanocortin 4 receptor deficiency.